Sponsor:
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Code:
NCT05128825
Conditions
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
azenosertib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-01. This information was provided to ClinicalTrials.gov by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc on 2025-05-21.